Moin Andrew
SAB Biotherapeutics, Inc. · Director
Moin Andrew is listed in filings as Director at SAB Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through Oct 1, 2025, including 5 public disclosures. Recent filings connect the profile to SAB Biotherapeutics, Inc. (SABS). The current snapshot covers public activity from Jul 24, 2025 to Oct 1, 2025. Reported amounts are shown as $25.0M to $40.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||